Peyronie's Disease Clinical Trials Peyronie's Disease RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Additional Xiaflex ® Treatment in Patients With Peyronie's Disease Recurrence, Worsening, or Incomplete Response
Condition:   Peyronie's Disease Intervention:   Drug: Xiaflex® 0.58 mg Sponsors:   Manhattan Medical Research Practice, PLLC;   Endo Pharmaceuticals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2018 Category: Research Source Type: clinical trials